Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals ; volume:24 ; number:1 ; day:12 ; month:2 ; year:2022 ; pages:1-5 ; date:12.2022
Arthritis Research & Therapy ; 24, Heft 1 (12.2.2022), 1-5, 12.2022
- Urheber
-
Guo, Qianyu
Gao, Jinfang
Duan, Jiaoniu
Hou, Ruihong
Lu, Tsung-Hsueh
Zhang, Liyun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-022-02720-1
- URN
-
urn:nbn:de:101:1-2022051819062433192057
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Guo, Qianyu
- Gao, Jinfang
- Duan, Jiaoniu
- Hou, Ruihong
- Lu, Tsung-Hsueh
- Zhang, Liyun
- SpringerLink (Online service)
Ähnliche Objekte (12)
Direct-acting antivirals and visceral leishmaniasis: a case report
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals
Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
Direct-acting antivirals and visceral leishmaniasis: a case report
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals
Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
Direct-acting antivirals and visceral leishmaniasis: a case report
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals